课题基金 / 基金详情

Phosphoproteomic Analyses of Understudied Protein Kinases that affect Zebrafish Sleep

Phosphoproteomic Analyses of Understudied Protein Kinases that affect Zebrafish Sleep
影响斑马鱼睡眠的正在研究的蛋白激酶的磷酸化蛋白质组学分析
批准号:
10437190
负责人:
Tsui-Fen Chou
金额:
$16.84万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-07-07 至 2023-06-30

项目摘要

项目成果

Tsui-Fen Chou的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 最近的两项研究发现,睡眠和醒来对大脑的磷酸蛋白质组有相反的影响。延长了 清醒会导致大脑中许多蛋白质的过度磷酸化,而睡眠则会促进 大脑蛋白质组的去磷酸化。盐诱导蛋白3(SIK3)的功能获得突变导致 一种类似于长时间清醒的大脑状态,与某一亚群的过度磷酸化有关 野生型动物在长时间清醒时过度磷酸化的蛋白质。这些 观察表明,蛋白质磷酸化可能在睡眠压力的积累中起作用 在睡眠期间消失的清醒状态,这种磷酸化部分是由sik3介导的,尽管它是 明确其他的蛋白激酶也参与其中。然而,这些蛋白激酶的特性仍然存在。 未知。基于一项大规模的(500,000名受试者)人类全基因组关联研究(GWAS),该研究发现 人类基因组中与人类睡眠变异和睡眠障碍相关的许多基因座,我们是 使用斑马鱼进行有针对性的遗传筛查,以确定每个基因座中的相关基因。其中四个 这个屏幕中的目标基因被列为“未被研究的蛋白质”,作为美国国立卫生研究院“照亮可药物”的一部分。 基因组“(IDG)计划。我们发现其中一个斑马鱼同源的功能丧失突变 人类基因会导致睡眠减少。我们将检验以下假设:(1)其他三个IDG基因作为靶点 在屏幕上还调节睡眠,以及(2)这些基因在大脑磷酸蛋白质组的变化中发挥作用 与睡眠或清醒有关。我们将通过测试每个突变体的睡眠来检验假设(1 使用运动活动和觉醒阈值分析的表型。对于假设(1)正确的基因, 我们将通过描述斑马鱼大脑磷酸蛋白质组对获得和损失的反应来检验假设(2)。 每个基因的功能外遗传扰动。这些实验将提供第一批演示的功能 对于正在测试的IDG基因,表征这些蛋白激酶对大脑磷酸蛋白质组的影响, 探索一种令人兴奋的新机制,这可能是睡眠动态平衡的基础。基于这些实验和 这个项目还将揭示一些观察到的人类睡眠和睡眠变化的基础 一些人类睡眠障碍,并为治疗这些障碍提供了新的可用药靶点。
英文摘要
ABSTRACT Two recent studies found that sleep and wake have opposing effects on the brain phosphoproteome. Prolonged wakefulness results in hyperphosphorylation of many proteins in the brain, whereas sleep promotes dephosphorylation of the brain proteome. A gain-of-function mutation in salt-inducible kinase 3 (sik3) results in a brain state similar to that of prolonged wakefulness and is associated with hyperphosphorylation of a subset of the proteins that are hyperphosphorylated in wild-type animals during prolonged wakefulness. These observations suggest that protein phosphorylation may play a role in the accumulation of sleep pressure during wakefulness that dissipates during sleep, and that this phosphorylation is mediated in part by sik3, although it is clear that additional protein kinases are involved. However, the identity of these protein kinases remains unknown. Based on a large (>500,000 subjects) human genome-wide association study (GWAS) that identified many loci in the human genome that are associated with human sleep variation and sleep disorders, we are performing a targeted genetic screen using zebrafish to identify the relevant gene in each locus. Four of the genes targeted in this screen are listed as “Understudied Proteins” as part of the NIH “Illuminating the Druggable Genome” (IDG) project. We have found that loss-of-function mutations in the zebrafish ortholog of one of these human genes results in decreased sleep. We will test the hypotheses that (1) the three other IDG genes targeted in the screen also regulate sleep, and that (2) these genes play roles in changes in the brain phosphoproteome that are associated with sleep or wakefulness. We will test hypothesis (1) by assaying each mutant for sleep phenotypes using locomotor activity and arousal threshold assays. For genes in which hypothesis (1) is correct, we will test hypothesis (2) by characterizing the zebrafish brain phosphoproteome in response to gain- and loss- of-function genetic perturbations of each gene. These experiments will provide the first demonstrated functions for the IDG genes being tested, characterize effects of these protein kinases on the brain phosphoproteome, and explore an exciting new mechanism that may underlie sleep homeostasis. Based on these experiments and human GWAS data, this project will also reveal the basis for some of the observed variation in human sleep and some human sleep disorders and provide new druggable targets to treat these disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using HTS to Identify Inhibitors of R155H-p97/VCP Mutant to treat IBMPFD/ALS
Dysregulation of p97/VCP disease mutants in IBM and FTLD-U
Dysregulation of p97/VCP disease mutants in IBM and FTLD-U
Dysregulation of p97/VCP disease mutants in IBM and FTLD-U
海外基金